Recent shortages of molybdenum-99 (99Mo) have led to an examination of alternate production methods that could contribute to a more robust supply. An electron accelerator and the photoneutron reaction were used to produce 99Mo from which technetium-99m (99mTc) is extracted. SPECT images of rat anatomy obtained using the accelerator-produced 99mTc with those obtained using 99mTc from a commercial generator were compared. Disks of 100Mo were irradiated with x-rays produced by a 35 MeV electron beam to generate about 1110 MBq (30 mCi) of 99Mo per disk. After target dissolution, a NorthStar ARSII unit was used to separate the 99mTc, which was subsequently used to tag pharmaceuticals suitable for cardiac and bone imaging. SPECT images were acquired for three rats and compared to images for the same three rats obtained using 99mTc from a standard reactor 99Mo generator. The efficiency of 99Mo–99mTc separation was typically greater than 90%. This study demonstrated the delivery of 99mTc from the end of beam to the end user of approximately 30 h. Images obtained using the heart and bone scanning agents using reactor and linac-produced 99mTc were comparable. High-power electron accelerators are an attractive option for producing 99Mo on a national scale.